SF002-96-1, a new drimane sesquiterpene lactone from an Aspergillus species, inhibits survivin expression

Scholarly Works

• Cui, Q.; Huang, C.; Liu, J.-Y.; Zhang, J.-T. Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective. Journal of medicinal chemistry 2023, 66, 16515–16545. doi:10.1021/acs.jmedchem.3c01130
• Yuan, J.; Liu, Z.; Dong, Y.; Gao, F.; Xia, X.; Wang, P.; Luo, Y.; Zhang, Z.; Yan, D.; Zhang, W. Pioneering 4,11-Dioxo-4,11-dihydro-1H-anthra[2,3-d]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy. Journal of medicinal chemistry 2023, 66, 16843–16868. doi:10.1021/acs.jmedchem.3c01551
• Li, M.; Zhao, Q.; Liao, J.; Wang, X.; Liu, L.; Zhang, X.; Liu, L.; Liu, H.; Zhang, S. Dioscin inhibiting EGFR-mediated Survivin expression promotes apoptosis in oral squamous cell carcinoma cells. Journal of Cancer 2023, 14, 2027–2038. doi:10.7150/jca.85011
• Gill, H.; Sykes, E. M. E.; Kumar, A.; Sorensen, J. L. Isolation of Bioactive Metabolites from Soil Derived Fungus-Aspergillus fumigatus. Microorganisms 2023, 11, 590. doi:10.3390/microorganisms11030590
• Albadari, N.; Li, W. Survivin Small Molecules Inhibitors: Recent Advances and Challenges. Molecules (Basel, Switzerland) 2023, 28, 1376. doi:10.3390/molecules28031376
• DU, W.; Yang, Q.; Xu, H.; Dong, L. Drimane-type sesquiterpenoids from fungi. Chinese journal of natural medicines 2022, 20, 737–748. doi:10.1016/s1875-5364(22)60190-0
• Huang, Y.; Valiante, V. Chemical Diversity and Biosynthesis of Drimane-Type Sesquiterpenes in the Fungal Kingdom. Chembiochem : a European journal of chemical biology 2022, 23, e202200173. doi:10.1002/cbic.202200173
• Beckmann, L.; Tretbar, U. S.; Kitte, R.; Tretbar, M. Anticancer Activity of Natural and Semi-Synthetic Drimane and Coloratane Sesquiterpenoids. Molecules (Basel, Switzerland) 2022, 27, 2501. doi:10.3390/molecules27082501
• Zhao, W.-Y.; Yi, J.; Chang, Y.-B.; Sun, C.-P.; Ma, X. Recent studies on terpenoids in Aspergillus fungi: Chemical diversity, biosynthesis, and bioactivity. Phytochemistry 2021, 193, 113011. doi:10.1016/j.phytochem.2021.113011
• Peery, R. C. Ph.D. Thesis, April 8, 2020.
• Lacey, H. J.; Gilchrist, C. L.; Crombie, A.; Kalaitzis, J. A.; Vuong, D.; Rutledge, P. J.; Turner, P.; Pitt, J. I.; Lacey, E.; Chooi, Y.-H.; Piggott, A. M. Nanangenines: drimane sesquiterpenoids as the dominant metabolite cohort of a novel Australian fungus, Aspergillus nanangensis. Beilstein journal of organic chemistry 2019, 15, 2631–2643. doi:10.3762/bjoc.15.256
• Song, Z.; Liu, Y.; Gao, J.; Hu, J.; He, H.; Dai, S.; Wang, L.; Dai, H.; Zhang, L.; Song, F. Antitubercular metabolites from the marine-derived fungus strain Aspergillus fumigatus MF029. Natural product research 2019, 35, 2647–2654. doi:10.1080/14786419.2019.1660331
• Li, F.; Aljahdali, I.; Ling, X. Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?. Journal of experimental & clinical cancer research : CR 2019, 38, 368. doi:10.1186/s13046-019-1362-1
• Kim, S.; Ko, D.; Lee, Y.; Jang, S.; Lee, Y.; Lee, I. Y.; Kim, S. Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4. Scientific reports 2019, 9, 10003. doi:10.1038/s41598-019-46447-7
• Shojaei, F.; Yazdani-Nafchi, F.; Banitalebi-Dehkordi, M.; Chehelgerdi, M.; Khorramian-Ghahfarokhi, M. Trace of survivin in cancer. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2019, 28, 365–372. doi:10.1097/cej.0000000000000453
• Martínez-García, D.; Manero-Rupérez, N.; Quesada, R.; Korrodi-Gregório, L.; Soto-Cerrato, V. Therapeutic strategies involving survivin inhibition in cancer. Medicinal research reviews 2018, 39, 887–909. doi:10.1002/med.21547
• Peery, R. C.; Liu, J.-Y.; Zhang, J. T. Targeting survivin for therapeutic discovery: past, present, and future promises. Drug discovery today 2017, 22, 1466–1477. doi:10.1016/j.drudis.2017.05.009
• Pandey, M. K.; Prasad, S.; Tyagi, A. K.; Deb, L.; Huang, J.; Karelia, D. N.; Amin, S.; Aggarwal, B. B. Targeting Cell Survival Proteins for Cancer Cell Death. Pharmaceuticals (Basel, Switzerland) 2016, 9, 11. doi:10.3390/ph9010011
• Shao, F.-Y.; Wang, S.; Li, H.-Y.; Chen, W.-B.; Wang, G.-C.; Ma, D.-L.; Wong, N.-S.; Xiao, H.; Liu, Q.-Y.; Zhou, G.-X.; Li, Y.-L.; Li, M.-M.; Yifei, W.; Liu, Z. EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells. Oncotarget 2016, 7, 6790–6808. doi:10.18632/oncotarget.6828
• Nadumane, V. K.; Venkatachalam, P.; Gajaraj, B. Aspergillus Applications in Cancer Research. New and Future Developments in Microbial Biotechnology and Bioengineering; Elsevier, 2016; pp 243–255. doi:10.1016/b978-0-444-63505-1.00020-8

Explore citations to this article at